Head-to-head dispatch
Peter MD vs Trinity Meds
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
A physician-prescribed telehealth brand pairing GLP-1 tirzepatide and compounded semaglutide+B12 with TRT, sermorelin, NAD+, hair-loss and ED care on one account — tirzepatide from $249/mo, semaglutide+B12 from $149/mo.
Marked down on: Tirzepatide steps up after month one — $149 for the first month, then $249/mo billed quarterly
Desk Score
Trinity Meds is a telehealth weight-loss program aimed at military women, spouses and veterans, offering compounded GLP-1 medication on an all-inclusive flat monthly rate: semaglutide at $149/month and…
Marked down on: Doesn't publish the states it serves — you only learn eligibility after starting the assessment
Peter MD takes this head-to-head with the higher Desk Score, 80/100 (B−) against 59/100 (C) for Trinity Meds. Trinity Meds still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Peter MD
80/100
B−
Trinity Meds
59/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Peter MD | Trinity Meds |
|---|---|---|
| Semaglutide | $149/mo (GLP1+B12, compounded, first-time tier; $139/mo returning-patient tier) | $149/mo (compounded) |
| Tirzepatide | $249/mo (60mg, billed quarterly; $149 first month) | $199/mo (compounded) |
| Coverage | Most states (restrictions vary by treatment — excludes several, incl. AL, ID) | Coverage not published |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Patients who want GLP-1 care alongside TRT, NAD+, sermorelin or other men's-health treatments under one physician-guided account, and don't need brand-name or oral routes. | Readers who want military women, spouses and veterans who want affordable all-inclusive compounded GLP-1 medication. |
| Desk Score | 80/100B− | 59/100C |
The verdict
Desk pick — Peter MDPeter MD takes this head-to-head with the higher Desk Score, 80/100 (B−) against 59/100 (C) for Trinity Meds. Trinity Meds still holds its ground where its strengths line up with yours.
Choose Peter MD if…
Patients who want GLP-1 care alongside TRT, NAD+, sermorelin or other men's-health treatments under one physician-guided account, and don't need brand-name or oral routes.
$149/mo (GLP1+B12, compounded, first-time tier; $139/mo returning-patient tier) sema · $249/mo (60mg, billed quarterly; $149 first month) tirz · Most states (restrictions vary by treatment — excludes several, incl. AL, ID)
Choose Trinity Meds if…
Readers who want military women, spouses and veterans who want affordable all-inclusive compounded GLP-1 medication.
$149/mo (compounded) sema · $199/mo (compounded) tirz · Coverage not published
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Peter MD · Trinity Meds.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Peter MD vs CoreAge Rx
- Trinity Meds vs Vaylen
- Peter MD vs Strut Health
- Trinity Meds vs Ondra Health
- Peter MD vs Invigor Medical
- Trinity Meds vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.